Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands

Psychopharmacology (Berl). 2008 Jan;196(1):39-49. doi: 10.1007/s00213-007-0925-6. Epub 2007 Oct 19.

Abstract

Rationale: The inbred Roman high- (RHA-I) and low-avoidance (RLA-I) rats, differing in dopaminergic activity and novelty/substance-seeking profiles, may be a suitable model to study the implication of the dopaminergic system in vulnerability to drug abuse. Differences in D3 receptor binding recently described between the two strains (Guitart-Masip M, Johansson B, Fernández-Teruel A, Cañete T, Tobeña A, Terenius L, Giménez-Llort L, Neuroscience 142:1231-1243, 2006b) may be important in shaping the aforementioned differences in novelty seeking.

Objective: The aim of the present work was to study the effect of D3 receptor activation on novelty-induced locomotor activity in these two strains of rats.

Materials and methods: We administered saline and PD-128,907 (0.01 and 0.1 mg/kg), a putative D3 receptor agonist, to the Roman rats and studied the locomotor activity when animals were placed in a novel environment. Thereafter, by means of in situ hybridization, nerve growth factor inducible clone A (NGFI-A) mRNA was measured in the striatum and the Calleja islands of these animals.

Results: We found that RLA-I rats showed stronger locomotor inhibition than RHA-I rats after PD-128,907 administration. Moreover, RLA-I rats showed stronger reduction of NGFI-A mRNA in the Calleja islands than RHA-I rats.

Conclusions: These results, together with previous findings, suggest that differences in D3 receptor expression in the Calleja islands may contribute to the divergent behavioral effect of PD-128,907 administration in the two strains of Roman rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Avoidance Learning / drug effects*
  • Benzopyrans / pharmacology*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine Agonists / pharmacology*
  • Dose-Response Relationship, Drug
  • Early Growth Response Protein 1 / genetics*
  • Exploratory Behavior / drug effects*
  • Gene Expression / drug effects
  • In Situ Hybridization
  • Inhibition, Psychological
  • Islands of Calleja / drug effects
  • Islands of Calleja / metabolism*
  • Male
  • Motor Activity / drug effects*
  • Oxazines / pharmacology*
  • RNA, Messenger / genetics*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine D3 / agonists*
  • Receptors, Dopamine D3 / genetics
  • Social Environment

Substances

  • Benzopyrans
  • Dopamine Agonists
  • Early Growth Response Protein 1
  • Egr1 protein, rat
  • Oxazines
  • RNA, Messenger
  • Receptors, Dopamine D3
  • 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol